TAK company logo

Takeda Pharmaceutical (TAK) Stock

NEW YORK STOCK EXCHANGE INC. · TAK
Trade TAK

Key stats

Market cap
$66.58B
Price / Earnings ratio
258.9x
EPS (TTM)
$0.08
Volume
Loading
52-week high
$21.73
52-week low
$13.78
EPS vs analyst estimate
-2.3%Q2 FY25 · $0.43 vs $0.44

Source: third-party data provider, as of November 13, 2026

EPS estimate: analyst consensus

Compare with TAK

Recent news

MarketBeat

What Takeda Pharmaceutical (TAK) Said on Its Q2 Earnings Call

PositiveTAKOctober 30, 2026
Business Wire

Takeda Announces FY2026 First-Half Results Highlighting Launch Momentum and Pipeline Milestones

NeutralTAKOctober 29, 2026
Business Wire

Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study

NeutralTAKOctober 23, 2026
Business Wire

First and Only Ulcerative Colitis Treat-to-Target Trial Shows Treating to Disease Clearance vs. Symptomatic Remission with ENTYVIO® (vedolizumab) Prolongs Time to First Disease-Related Complication

NeutralTAKOctober 19, 2026

News tone: automated (AI) classification of the article's content, not a price prediction.

Technical indicators

RSI 14
63.49
MACD 12/26/9
0.55
EMA 9 of MACD
0.56
MACD histogram
-0.01
SMA 50
$19.29
Price above SMA 50
EMA 50
$19.47
Price above EMA 50
SMA 200
$17.74
Price above SMA 200
EMA 200
$17.77
Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst ratings

No analyst data available

Financials

Performance

Revenue
Net income
Net margin %
2022
2023
2024
2025
2026
380B251B126B0

Debt & Balance Sheet

Total assets
Total liabilities
2022
2023
2024
2025
2026
19T12T6T0

Revenue to Profit

2026
$28.4B
Revenue
$0.0
Cost of revenue
$2.9T
Gross profit
$0.0
Operating expenses
$-152.4B
Net income

Earnings

EPS forecast
Actual EPS
$0.43
$0.44
Q2FY25
$0.55
Q3FY25
$0.28
Q4FY25
$0.45
Q1FY26
$0.45
Q2FY26

The market is expecting earnings per share of $0.45 for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

Stocks in the same sector

PRGO
Perrigo
ZTS
Zoetis
ALKS
Alkermes plc
AMRX
Amneal Pharmaceuticals Inc.
AMPH
Amphastar Pharmaceuticals Inc
ANIP
ANI Pharmaceuticals Inc
ACB
Aurora Cannabis
BHC
Bausch Health

FAQ

Buying Takeda Pharmaceutical (TAK) stock is now easy and instant through the Gotrade app.
  1. Download the Gotrade app from the App Store or Google Play.
  2. Create an account and verify your identity.
  3. Make a deposit.
  4. Search for the code "TAK", then tap "Trade".
  5. Tap the "Buy" button.
  6. Enter the amount you want to buy. You have two options:
    1. Buy TAK by number of shares.
    2. Buy fractional shares in dollars, starting from $1.
  7. Swipe up to confirm your order, and you're done!
On Gotrade, you don't have to buy a full share. With fractional shares, you can start investing in Takeda Pharmaceutical from just $1. A small budget shouldn't stop you from building a US stock portfolio.
At the moment, Takeda Pharmaceutical (TAK) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track TAK's performance via the price chart in the Gotrade app.
Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).
You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too.
The market is closed on US public holidays. The Gotrade app shows whether the market is open.
There's no single perfect answer, but common approaches include:
  • Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
  • Review revenue and earnings growth.
  • Check margins and cash flow.
  • Evaluate business outlook and the company's position within its industry.
You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.
Mockup Two Phones

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Gotrade Green Logo Top Left

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply